No abstract available
MeSH terms
-
Adult
-
Animals
-
Arginine / pharmacology
-
Atorvastatin
-
Brain Ischemia / etiology
-
Brain Ischemia / prevention & control
-
Cerebrovascular Circulation / drug effects*
-
Clinical Trials, Phase II as Topic
-
Endothelium, Vascular / drug effects
-
Heptanoic Acids / pharmacology
-
Heptanoic Acids / therapeutic use
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology*
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
-
Hypercholesterolemia / complications
-
Hypertension / complications
-
Intracranial Aneurysm / complications
-
Mice
-
Middle Cerebral Artery / diagnostic imaging
-
Nitric Oxide / physiology
-
Pravastatin / pharmacology
-
Pravastatin / therapeutic use
-
Pyrroles / pharmacology
-
Pyrroles / therapeutic use
-
Randomized Controlled Trials as Topic
-
Research Design
-
Risk Factors
-
Simvastatin / pharmacology
-
Simvastatin / therapeutic use
-
Stroke / prevention & control
-
Subarachnoid Hemorrhage / drug therapy
-
Subarachnoid Hemorrhage / etiology
-
Ultrasonography, Doppler, Transcranial
-
Vasodilation / drug effects
-
Vasomotor System / drug effects*
-
Vasospasm, Intracranial / drug therapy
-
Vasospasm, Intracranial / etiology
Substances
-
Heptanoic Acids
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Pyrroles
-
Nitric Oxide
-
Arginine
-
Atorvastatin
-
Simvastatin
-
Pravastatin